Himalaya vs Patanjali Ashwagandha

A quick primer for readers comparing these for the first time

If you're new to ashwagandha entirely and you opened this comparison hoping it would tell you which one to buy: stay with me, because the structure of this comparison is going to be more useful to you than a verdict would be.

Ashwagandha (Withania somnifera) is an Indian herb with the strongest clinical-trial base of any single herb in Ayurveda — 22 RCTs covering stress, cortisol, sleep, strength, and other outcomes. The herb itself works in the trials. The question is whether any specific retail product delivers what the trials measured.

Himalaya and Patanjali are the two highest-volume Indian retail ashwagandha brands. Neither uses a clinically-tested branded extract. Neither discloses withanolide percentage on the box. Both are FSSAI-registered. Both have decades of manufacturing experience.

This article compares them so that you can see exactly what each label tells you and what each one doesn't. If neither product matches what you're looking for, the related links at the bottom point to brands with more disclosure, branded-extract use, or different price-evidence trade-offs.

Why this comparison exists

These are the two most-sold Ayurveda labels in Indian pharmacies. They retail for a combined market that crosses Rs 2,000 crore annually across all SKUs, and yet I could not find a single article online that simply put their two ashwagandha boxes side-by-side without trying to crown a winner.

I bought both from an MedPlus near Clock Tower in Dehradun on April 4, 2026. I am reporting what is printed on the box. Where a brand does not disclose something, I say so — that is information, not criticism.

The headline numbers

The label-by-label table

This is the section that took me an hour with a magnifying glass and the FSSAI website. Every entry is sourced from the physical packaging.

What each brand actually claims on its packaging

Direct quotes, attributed, in their own words. I have not paraphrased.

What the published clinical evidence shows for each SKU

This is the section I think readers will find most uncomfortable, because it is not what either brand wants you to know.

That is a fact, not a criticism. The branded ashwagandha extracts that do have clinical trials behind them — KSM-66 (Ixoreal Biomed) and Sensoril (Natreon) — are not used by either brand.

Both brands appear to assume that the trial data on the underlying herb (Withania somnifera) generalises to their formulations. That is a reasonable but not airtight assumption.

What "root extract 250 mg" vs "whole plant 500 mg" actually means

This is the line on the label most readers will struggle to interpret, and it deserves a proper explanation.

When Himalaya prints "Withania somnifera (root extract) 250 mg" they mean: 250 mg of a concentrated extract derived from ashwagandha root. The extract is the result of processing dried root through solvent extraction and removing the inactive plant fibre, leaving a more concentrated fraction of withanolides and other active compounds. 250 mg of root extract is roughly equivalent — in active content — to a much larger weight of whole-plant powder.

When Patanjali prints "Withania somnifera 500 mg (whole plant)" they mean: 500 mg of dried, milled whole-plant material — root, stem, leaf, sometimes seed. There is no extraction step concentrating the active fraction. 500 mg of whole plant powder contains a smaller absolute amount of withanolides than 250 mg of standardised extract.

The two labels are not telling you the same thing. They are telling you about two different starting materials.

Why neither brand discloses withanolide percentage — a structural answer

Reader who asks: "if KSM-66 can put '5% withanolides' on the label, why can't Himalaya or Patanjali?"

Short answer: they could. They choose not to.

Long answer: branded extract manufacturers like Ixoreal Biomed (KSM-66) and Natreon (Sensoril) compete on standardisation transparency. Their entire commercial model is "we measure the active fraction, we put the number on every batch, we stake our brand on it." That model funds their clinical trials.

Generic-extract retail brands compete on something else — distribution, brand familiarity, price, breadth of product range. Their commercial model does not require them to defend a specific withanolide percentage on every batch, so they do not commit to one publicly.

This is not a moral failing. It is a structural difference in how the two business models work. But it does mean that when you compare a Himalaya label to a Carbamide Forte KSM-66 label, you are comparing two products that are competing on entirely different attributes.

What three years of selling at this scale tells us about safety

Both Himalaya and Patanjali have been selling these specific ashwagandha SKUs at large volumes for years. That gives us a different kind of evidence than RCTs — pharmacovigilance data from a real-world consumer base.

I searched the published literature in April 2026 for reported adverse events specifically attributed to either Himalaya Ashwagandha caplet or Patanjali Divya Ashwagandha capsule. I did not find peer-reviewed case reports of serious adverse events attributable to either specific SKU.

This is not the same as "they are safe." Pharmacovigilance reporting in India is uneven, and the existence of the broader 2023 ashwagandha-induced liver injury case series (Philips et al., Hepatology Communications) means the herb category overall is no longer in the "essentially benign" zone I'd have placed it in pre-2020.

What it does mean is that the case literature has not flagged either of these specific products as outliers in safety. Combined with the FSSAI registration both maintain, that is a small but real signal.

How I would compare these two if the labels were the only thing in front of me

Without clinical trial data on either specific SKU, the questions reduce to label-quality questions.

Himalaya is more transparent about extract type (root extract printed on the box). Patanjali is cheaper (Rs 1.33 vs Rs 2.92 per serving). Neither discloses withanolide percentage. Both are FSSAI-registered. Both have FSSAI numbers that verify on fssai.gov.in. Neither uses a branded clinically-tested extract.

If I were forced to pick one for a hypothetical reader who insisted on choosing between just these two, I'd ask the reader what they were optimising for. Cheapness — Patanjali. Slightly clearer labelling — Himalaya. Best clinical evidence — neither, look at Carbamide Forte's KSM-66 product or Nature's Velvet's Sensoril product instead.

That is exactly the kind of unsexy answer that does not perform well on Instagram and that I think readers actually deserve.

Pricing — the math nobody does

Most price-comparison articles stop at MRP. The more useful number is price per gram of withanolide, because withanolides are the active fraction the trials measure.

Neither brand discloses withanolide percentage. So instead, here's the math you can do today:

A note on quality control across the two manufacturers

Both Himalaya and Patanjali operate at industrial scale. Both have to manage the same fundamental quality-control problem with ashwagandha: the active compound (withanolide) content varies depending on plant source, harvest season, soil conditions, and processing method.

Himalaya operates ICH/cGMP-certified manufacturing facilities and publishes broader corporate-level quality documentation. Their R&D infrastructure has been published-on for years, including in non-India journals. They control sourcing through long-term contracts with growers, primarily in Madhya Pradesh and Rajasthan.

Patanjali operates Divya Pharmacy as the Ayurvedic medicine arm, with manufacturing centred around Haridwar. Their corporate documentation around quality control is less detailed than Himalaya's in the public domain, though both maintain FSSAI registration and meet baseline GMP standards.

I am not going to call one "higher quality" than the other on this evidence. What I will say is that the publicly verifiable quality-control documentation differs in depth, and a reader who values that documentation will find more of it for Himalaya than for Patanjali. Whether that translates into product-level quality differences in any individual bottle is unknown without independent batch testing.

What an independent batch test of these two products would actually show

This is where I'd love to give you analytical chemistry data. I don't have it for these specific products, and I am not going to pretend otherwise.

What we do have, by extension, is the broader Indian Ayurvedic supplement quality-control literature. A 2023 Journal of Ethnopharmacology survey of Indian retail Ayurvedic products found inter-batch variability in active compound content of 15-40% across multiple herb categories. Heavy-metal contamination was below limits in most but not all sampled products. FSSAI registration was correlated with cleaner profiles than non-registered products, but registration alone did not eliminate variability.

Translated to ashwagandha specifically: a randomly purchased Himalaya caplet probably delivers between 4-8 mg of total withanolides per caplet, given typical batch variability for unstandardised Indian root extract products. A randomly purchased Patanjali whole-plant capsule probably delivers 1-3 mg of withanolides, given the lower concentration in unprocessed plant material.

These are inferences, not measurements. They are the right order of magnitude based on the Indian retail supplement literature, but they should be treated as estimates only.

The cleaner conclusion: the difference between the two products is meaningful. The exact magnitude of the difference is unknown without per-bottle testing.

What this comparison means in the context of the broader 8-brand list

If you came to this article from our ashwagandha scorecard or from a "best ashwagandha brand" search, you are probably also weighing other Indian options. So let me place these two in that broader context.

Himalaya and Patanjali are the two highest-volume Indian retail ashwagandha brands by units sold. Neither of them sits at the high-evidence end of the spectrum. Both compete on distribution, brand recognition, and price. Neither uses a clinically-tested branded extract.

The brands that do use branded extracts in India — Carbamide Forte (KSM-66), Nature's Velvet (Sensoril), and a few smaller players — sit at higher price points but match the trial literature more directly.

Reading this comparison and asking "which is better, Himalaya or Patanjali?" is a fair question. Reading this comparison and asking "should I be looking at a third option entirely?" is a better one.

Why brand familiarity is not the same as brand quality

I want to close on this point because it is the single biggest factor I see in how Indian consumers actually choose between these two products.

Most readers of this article will choose one based on familiarity. They have been seeing Himalaya products in their parents' bathrooms for thirty years. They have been buying Patanjali toothpaste since 2015. The brand is already part of their household trust map.

Brand familiarity is not a bad heuristic. Both companies have been operating long enough that gross safety failures would have shown up by now. Both maintain regulatory registration. Both have customer service infrastructure.

What brand familiarity is not: a substitute for label literacy. The same trusted brand can sell you a clinically-defensible product (Himalaya Liv.52, which has been studied in indexed liver-function trials) and a less-evidenced one (Himalaya Ashwagandha caplet, which has not). Reading the label is what tells you which is which.

That is the meta-lesson of this entire article. The brand is not the product. The label is the product. And the label, in both cases here, is telling you less than you deserve to know.

Questions to ask yourself before buying either

This article is built to leave the choice with you, not with me. Some questions that might be useful:

Frequently asked questions

Related reads on HerbVerdict